Pfizer expects to make $15 billion in sales from its COVID-19 vaccine in 2021

US pharmaceutical giant Pfizer expects the coronavirus vaccine it developed with BioNTech, the first to be authorized for emergency use in the West, to make it about $15 billion in revenues in 2021.

Read More